Growth and differentiation factors are known to play regulatory roles in the cardiovascular response to stress and injury, such as the hypertrophic response of cardiac and arterial smooth muscle to hypertension, the response of vascular endothelium and smooth muscle to injury after angioplasty, and also in the repair and protective responses of the heart and vasculature to ischemic attack. To study these responses at the whole animal level, we have genetically engineered mice in which two of these growth factors, transforming growth factor beta-1 (TGFbeta1) and basic fibroblast growth factor (FGF2) have been ablated or overexpressed, respectively. The TGFbeta1-deficient mouse displays impaired cardiac contractility, abnormal vascular smooth muscle cell (VSMC) growth, and poor platelet aggregation. Many of these phenotypes implicate abnormal Ca2+ handling as the molecular basis of the defects. The transgenic FGF2 mouse has impaired VSMC growth. To these animal resources we will add FGF2 knockout mice which are deficient in specific FGF2 isoforms thought to play differential functional roles in the cardiovascular system. Finally, we will continue to develop tissue-specific, or conditional, knockout schemes in order to ablate gene function only in specific tissues of the animal. With these animal models we will investigate i) the role of TGFbeta1 in regulating Ca2+ flux in cardiomyocytes, ii) the roles of TGFbeta1 and FGF2 in the development of cardiac hypertrophy and the resulting switch in muscle protein isoforms, iii) the regulatory role of TGFbeta1 in platelet function, iv) the protective roles of FGF2 and TGFbeta1 in ischemia- reperfusion injury, v) development of microvasculature, and vi) growth control in vascular smooth muscle and endothelium after de-endothelization. Physiological approaches at the whole animal, whole organ and isolated cell levels will include echo Doppler cardiography, work-performing and Langendorff whole heart preparations, isolated cardiac cell mechanics, Ca2+ transient measurements,a nd single ion channel recordings and VSMC and endothelial cell culture. Altered expression of factors that co-regulate cardiovascular functions with TGFbeta and FGF, and of downstream effectors of TGFbeta1 and FGFbeta1 and GGF2 will be measured. With these studies we will obtain more definitive information on the roles of growth factors in contractility, cardiac and VSMC hypertrophy, ischemia-reperfusion injury, neovascularization, arterial injury, and platelet dysfuncTIon.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL041496-11
Application #
6109939
Study Section
Project Start
1998-12-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
11
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Type
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Sadayappan, Sakthivel; Finley, Natosha; Howarth, Jack W et al. (2008) Role of the acidic N'region of cardiac troponin I in regulating myocardial function. FASEB J 22:1246-57
Pattison, James Scott; Waggoner, Jason R; James, Jeanne et al. (2008) Phospholamban overexpression in transgenic rabbits. Transgenic Res 17:157-70
Kalinichenko, Vladimir V; Gusarova, Galina A; Kim, Il-Man et al. (2004) Foxf1 haploinsufficiency reduces Notch-2 signaling during mouse lung development. Am J Physiol Lung Cell Mol Physiol 286:L521-30
Small, Kersten M; McGraw, Dennis W; Liggett, Stephen B (2003) Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 43:381-411
Sanbe, Atsushi; Gulick, James; Hanks, Mark C et al. (2003) Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ Res 92:609-16
Liggett, Stephen B (2003) Polymorphisms of adrenergic receptors: variations on a theme. Assay Drug Dev Technol 1:317-26
Golovina, Vera A; Song, Hong; James, Paul F et al. (2003) Na+ pump alpha 2-subunit expression modulates Ca2+ signaling. Am J Physiol Cell Physiol 284:C475-86
Kalinichenko, Vladimir V; Zhou, Yan; Shin, Brian et al. (2002) Wild-type levels of the mouse Forkhead Box f1 gene are essential for lung repair. Am J Physiol Lung Cell Mol Physiol 282:L1253-65
Whitsett, Jeffrey A; Clark, Jean C; Picard, Lara et al. (2002) Fibroblast growth factor 18 influences proximal programming during lung morphogenesis. J Biol Chem 277:22743-9
Lim, Lorena; Kalinichenko, Vladimir V; Whitsett, Jeffrey A et al. (2002) Fusion of lung lobes and vessels in mouse embryos heterozygous for the forkhead box f1 targeted allele. Am J Physiol Lung Cell Mol Physiol 282:L1012-22

Showing the most recent 10 out of 257 publications